Albani M
Neuropadiatrie. 1977 Aug;8(3):286-92. doi: 10.1055/s-0028-1091524.
Fifteen infants and children were treated with phenytoin for status epilepticus. They received doses 31.5 mg/kg (18--46) in the first 24 hours, 18.5 mg/kg (10--28) on the second day and 11 mg/kg (7.7--15.4) on the third day controlled by frequent serum level determinations. After reaching the upper therapeutic range (8--25 microgram/ml) within 24 hours these serum concentrations were maintained over the next days. Twelve of fifteen--including five newborns and infants below four months of age--were thus successfully treated; the remaining three in whom phenytoin had no effect, no other anticonvulsant drug or a combination of several other drugs were successful. A dose schedule based upon serial serum concentration measurements is given. It enables an efficient phenytoin treatment of status epilepticus or equivalent convulsive states in infancy and childhood.
15名婴幼儿因癫痫持续状态接受苯妥英治疗。他们在最初24小时内接受31.5毫克/千克(18 - 46)的剂量,第二天接受18.5毫克/千克(10 - 28),第三天接受11毫克/千克(7.7 - 15.4),通过频繁测定血清水平进行控制。在24小时内达到治疗上限范围(8 - 25微克/毫升)后,接下来几天维持这些血清浓度。15名患者中有12名——包括5名新生儿和4个月以下的婴儿——因此得到成功治疗;其余3名对苯妥英无反应的患者,使用其他抗惊厥药物或几种其他药物联合使用均未成功。给出了基于系列血清浓度测量的给药方案。它能够对婴幼儿期和儿童期的癫痫持续状态或等效惊厥状态进行有效的苯妥英治疗。